BIOLOGY · GENETICS · HUMAN GENETICS

Trace the family.
Then bound the inference.

Use pedigrees, penetrance, expressivity, complex-trait evidence, and test denominators without turning a pattern, association, or detected variant into certainty.

Start the lessons ↓Go to practice →
3guided lessons
12practice questions
5choices per item
$0free, always

The Human Genetics reasoning loop

Use one observation-model-evidence ledger.

  1. 01Observe

    Record phenotype, relationships, population, and the supplied reference standard.

  2. 02Assume

    Write penetrance, family-size, inheritance-system, and sampling assumptions.

  3. 03Test

    Check every transmission edge or every cell in the supplied table.

  4. 04Quantify

    Choose the correct denominator before calculating a proportion.

  5. 05Bound

    Separate consistency, association, causality, prediction, and personal advice.

Human-genetics instruction is cross-checked against NIH MedlinePlus Genetics ↗.

Three linked lessons

From family pattern to evidence-bounded interpretation.

Treat pedigree symbols as observations, penetrance and expressivity as different quantities, and test results as conditional evidence rather than automatic diagnosis or destiny.

01

LESSON 1 · 21 MIN

Study + retrieve

Pedigree evidence and inheritance models

Use a bounded pedigree to test autosomal, sex-linked, and mitochondrial inheritance models while distinguishing a model that is consistent from one that is uniquely established.

ESSENTIAL QUESTIONWhich candidate models survive every observed parent-to-offspring relationship, and what assumptions limit the conclusion?
Pedigree transmission-constraint mapA text-labeled pedigree reasoning map begins by separating observed phenotype from inferred genotype and asking the learner to trace every parent-to-offspring edge. Four model cards show simplified expectations under stated assumptions. Autosomal recessive inheritance can produce an affected child from two unaffected carriers. Autosomal dominant inheritance with complete penetrance often shows an affected parent but is not proven by vertical appearance alone. In a typical XX/XY system, a father passes his X chromosome to daughters and Y chromosome to sons, so direct father-to-son X-linked transmission is impossible. A simplified mitochondrial model shows transmission through an affected mother but not an affected father. The footer says that a model consistent with a small pedigree is not necessarily uniquely proven, and that penetrance, de novo change, family size, and mating assumptions can alter appearances. Every relationship and state is labeled in text rather than encoded by color alone.PEDIGREE REASONING · OBSERVATION BEFORE MODEL1 · LABELphenotype · sex · relationships2 · TRACEevery parent → offspring edge3 · STATEpenetrance · family size · systemTEST EACH CANDIDATE AGAINST EVERY EDGEAUTOSOMAL RECESSIVEunaffected carrierscan have affected childAUTOSOMAL DOMINANTvertical pattern plausiblenot proven by one featureX-LINKED · XX/XYfather X → daughtersfather Y → sonsMITOCHONDRIAL · SIMPLEaffected mother transmitsaffected father does notCONSISTENT WITH A SMALL PEDIGREE ≠ UNIQUELY PROVENPENETRANCE · DE NOVO CHANGE · FAMILY SIZE · MATING ASSUMPTIONS CAN ALTER APPEARANCESTUDY DIAGRAM · TEXT DESCRIPTION AVAILABLE
01

Translate the pedigree before naming a model

A pedigree records relationships, observed phenotype, and generations; it does not directly reveal every genotype. First mark who is affected, which parents produced which offspring, and whether each sex is represented. Then write any supplied assumptions such as complete penetrance, rare outside alleles, or a typical XX/XY system.

  • Phenotype symbol ≠ known genotype
  • Trace each parent–offspring edge
  • List assumptions before inference
02

Test transmission constraints

Under a simple complete-penetrance model, unaffected carrier parents can produce an affected child for an autosomal recessive trait, while an autosomal dominant trait often shows an affected parent. In a typical XX/XY system a father gives his X chromosome to daughters and Y chromosome to sons, so he cannot transmit an X-linked allele directly to a son. Simplified mitochondrial pedigrees commonly show maternal-line transmission because most zygote cytoplasm comes from the oocyte.

  • Autosomal recessive can skip generations
  • Father’s X → daughters; Y → sons
  • Simplified mtDNA transmission follows mother
03

Stop at consistency when evidence is limited

A small pedigree can fit more than one inheritance model, especially when family size, penetrance, de novo change, mating genotype, or phenotype classification is uncertain. Vertical appearance can support an autosomal dominant model without proving it. Prefer ‘consistent with’ unless all stated alternatives are excluded by the supplied evidence.

  • Consistent ≠ uniquely proven
  • Small samples hide possible transmissions
  • Penetrance can obscure a generation

Worked example

In a small pedigree, an affected mother has three affected children and an affected father has two unaffected children. Which conclusion is justified under a simplified mitochondrial model?

  1. 1

    Maternal transmission to all observed children matches the simplified model.

  2. 2

    No observed transmission from the affected father also matches the model.

  3. 3

    The family is small, so the pattern supports but does not uniquely prove mitochondrial inheritance.

ConclusionMitochondrial inheritance is consistent with the observations under the stated simplified model; the pedigree alone is not unique proof.

Close the notes first

Retrieve the evidence boundary.

01Can an unaffected parent carry an autosomal recessive allele?
Yes; a heterozygous carrier can be unaffected under a complete-recessive model.

Phenotype does not reveal both alleles in a recessive system.

02Can a father transmit his X chromosome directly to a typical XY son?
No; he contributes the Y chromosome to that son.

The son’s X chromosome comes from the other parent in the stated system.

03What does a pattern in every generation prove?
It can support vertical inheritance, but does not alone prove one model.

Penetrance, family size, de novo change, and other models can produce similar appearances.

02

LESSON 2 · 20 MIN

Study + retrieve

Penetrance, expressivity, and complex traits

Distinguish whether a genotype is expressed, how its expression varies, and how multiple loci and environments contribute probabilistically to a human phenotype.

ESSENTIAL QUESTIONIs the evidence about the fraction expressing a genotype, the form or severity among those expressing it, or a multivariable probability?
Penetrance, expressivity, and complex-trait ledgerThe upper panel shows one hundred people with a specified genotype represented as a labeled group. Seventy-two meet the phenotype definition and twenty-eight do not, yielding seventy-two percent observed penetrance for the stated observation window. A separate band within the expressing group ranges from mild to moderate to strong presentation, labeled variable expressivity. The lower panel separates a single observed trait from several possible contributors: multiple genomic loci, environment, development, age, and measurement. Arrows converge on a probability distribution rather than one guaranteed outcome. A note states that twin concordance below one hundred percent can be compatible with both genetic contribution and nonshared influences but cannot by itself assign exact causal percentages. The footer distinguishes whether a phenotype occurs from how it appears and from the probability produced by multiple contributors; all categories use text and pattern, not color alone.PENETRANCE · WHETHER THE DEFINED PHENOTYPE OCCURS25 tiles × 4 carriers = 10018 tiles = 72 expressing · 7 = 28 notobserved penetrance = 72 / 100 = 72%EXPRESSIVITY · HOW IT APPEARS AMONG THOSE EXPRESSINGMILDMODERATESTRONGCOMPLEX TRAIT · CONTRIBUTORS CHANGE A DISTRIBUTIONLOCUS 1LOCUS 2ENVIRONMENTDEVELOPMENTAGE + MEASURECONTRIBUTION CHANGES PROBABILITY · IT DOES NOT GUARANTEE ONE INDIVIDUAL OUTCOMESTUDY DIAGRAM · TEXT DESCRIPTION AVAILABLE
01

Define penetrance over a stated group and window

Penetrance is the proportion of people with a specified genotype who show the defined phenotype under a stated observation window. If 60 of 80 carriers meet the phenotype definition, observed penetrance is 75 percent. It does not mean that each individual is three-quarters affected, and age or ascertainment can change the observed estimate.

  • Penetrance = expressing carriers ÷ all carriers
  • Group proportion, not symptom severity
  • Define age and observation window
02

Use expressivity for variation among those affected

Expressivity describes differences in the form, features, or severity of a phenotype among people who express the genotype. Two people can both count as penetrant while one has a mild presentation and another a strong presentation. Expressivity is therefore not the fraction of carriers who show any phenotype.

  • Penetrance asks whether
  • Expressivity asks how
  • Same genotype can show different forms
03

Treat complex traits as multivariable

Polygenic traits reflect contributions from multiple loci, and many are also multifactorial because environments contribute. A risk-associated allele can change a group-level probability without guaranteeing an individual outcome. Twin concordance below 100 percent can be compatible with genetic contribution plus environmental, developmental, or stochastic differences; it does not quantify each cause by itself.

  • Several loci can contribute
  • Environment can modify outcome
  • Association changes probability, not certainty

Worked example

Among 100 people with a specified genotype, 72 meet the phenotype definition; those 72 range from mild to severe. What do the two observations measure?

  1. 1

    The denominator for penetrance is all 100 genotype carriers.

  2. 2

    Seventy-two express the defined phenotype, so observed penetrance is 72 percent.

  3. 3

    The range from mild to severe among expressing individuals describes variable expressivity.

ConclusionThe group has 72 percent observed penetrance under the stated definition and variable expressivity among those who express the phenotype.

Close the notes first

Retrieve the evidence boundary.

01What denominator is used for penetrance?
All people in the defined group who carry the specified genotype.

Penetrance asks what fraction of genotype carriers express the phenotype.

02What does variable expressivity compare?
The form or severity of the phenotype among people who express it.

It is variation in manifestation, not the proportion who manifest at all.

03Does a risk-associated allele guarantee the associated phenotype?
No; it changes a probability in a defined population and context.

Other loci, environment, age, and measurement can affect outcome.

03

LESSON 3 · 22 MIN

Study + retrieve

Genetic tests, predictive value, and evidence boundaries

Interpret supplied sensitivity, specificity, predictive-value, prevalence, and variant-evidence data without turning a test result or association into certainty or personal medical advice.

ESSENTIAL QUESTIONWhat exactly did the assay detect, relative to which reference standard and population, and what conclusion does the evidence support?
Genetic-test denominator and evidence-boundary mapA two-by-two table places reference condition present and absent in columns and test positive and negative in rows. The cells are labeled true positive, false positive, false negative, and true negative. Beside the table, formulas define sensitivity as true positives divided by true positives plus false negatives, specificity as true negatives divided by true negatives plus false positives, and positive predictive value as true positives divided by all positive tests. A population panel says that predictive value changes with prevalence or prior probability even if sensitivity and specificity are unchanged. An evidence ladder separates variant detection, statistical association, uncertain classification, supported causality, and phenotype prediction rather than collapsing them into one claim. A variant of uncertain significance is labeled insufficient evidence, not a diagnosis. The footer states that a positive result is not automatically causal or certain and that classroom examples do not provide personal medical advice. Text labels make every distinction available without color.FIRST CHOOSE THE CONDITIONING GROUPCONDITION +CONDITION −TEST +TEST −TRUE +FALSE +FALSE −TRUE −SENSITIVITYTP / (TP + FN)SPECIFICITYTN / (TN + FP)POSITIVE PREDICTIVE VALUETP / (TP + FP)PREVALENCE / PRIOR PROBABILITY CHANGES PREDICTIVE VALUEKEEP THE EVIDENCE CLAIM AT ITS ACTUAL LEVELDETECTEDASSOCIATEDVUSCAUSAL SUPPORTPHENOTYPE RISKPOSITIVE ≠ CAUSAL ≠ CERTAIN FUTURE PHENOTYPE · NO PERSONAL MEDICAL ADVICESTUDY DIAGRAM · TEXT DESCRIPTION AVAILABLE
01

Anchor test metrics to the correct denominator

Sensitivity is the fraction testing positive among those who truly have the defined condition: TP divided by TP plus FN. Specificity is the fraction testing negative among those without it: TN divided by TN plus FP. Positive predictive value is the fraction of positive tests that are true positives: TP divided by TP plus FP.

  • Sensitivity denominator: condition present
  • Specificity denominator: condition absent
  • PPV denominator: all positive tests
02

Connect predictive value to prior probability

Even when sensitivity and specificity stay the same, predictive values depend on prevalence or prior probability in the tested population. With lower prevalence, false positives can make up a larger share of positive results; with higher prevalence, positive predictive value generally rises. Use the supplied 2-by-2 table rather than swapping conditional probabilities.

  • P(test positive | condition) ≠ P(condition | test positive)
  • Prevalence changes predictive value
  • Read row and column totals
03

Separate detection, association, classification, and outcome

Detecting a variant does not automatically prove it causes a condition, is pathogenic, or predicts a phenotype with certainty. A variant of uncertain significance explicitly lacks enough evidence for a disease relationship. Statistical association can nominate a candidate, but causal inference may require segregation, functional, replication, and other evidence. Classroom interpretation does not replace genetic counseling or personal medical care.

  • Detected ≠ causal
  • VUS means evidence is insufficient
  • Population association ≠ individual diagnosis

Worked example

A study table reports 30 true positives and 20 false positives among all positive tests. What is the positive predictive value in that study sample?

  1. 1

    Positive predictive value uses all positive tests as its denominator.

  2. 2

    There are 30 + 20 = 50 positive tests.

  3. 3

    Divide 30 true positives by 50 total positives.

ConclusionThe positive predictive value in the supplied sample is 60 percent; that value need not transfer unchanged to a population with different prevalence.

Close the notes first

Retrieve the evidence boundary.

01What is the denominator for sensitivity?
All people who truly have the defined condition: true positives plus false negatives.

Sensitivity conditions on the reference-positive group.

02Why can PPV change when sensitivity and specificity do not?
The tested population’s prevalence or prior probability can change.

That changes the mixture of true and false positives among positive tests.

03What does a variant of uncertain significance establish?
The available evidence is insufficient to determine whether the variant is related to the condition.

Uncertain classification is not evidence of benignity, pathogenicity, or a diagnosis.

Randomized retrieval set

Now identify the inheritance constraint, denominator, or evidence level.

Pedigrees, transmission, penetrance, expressivity, polygenic contribution, twin concordance, predictive value, prevalence, VUS classification, and association boundaries are interleaved.

12 PRACTICE QUESTIONS

Retrieve before you review.

Question order and all five answer options are shuffled when you begin. The correct answer stays attached to the same underlying choice.

Scope and score notice

Human Genetics foundations, not a score prediction or diagnosis.

The ADA lists Human genetics within Genetics but does not publish a subtopic item quota. DAT TRAIN does not invent one.

Named disorders, personal recurrence counseling, disease-specific testing recommendations, treatment decisions, unsupplied risk percentages, detailed variant-classification frameworks, and clinical interpretation remain outside this route.

Use your results to choose what to review next—not as an official DAT score prediction.